IGF1 and neoplasm: These stimulated PSCs react by increasing stromal production of growth factors like insulin-like growth factor 1 (IGF1) and growth arrest-specific gene 6 (GAS6), which in turn affect the phosphoproteome of KRAS-mutant tumor cells.